Clinical Scorecard: The Impact of Asthma on Bone Health: Understanding the Dual Influence of the Condition and Its Treatments
At a Glance
Category
Detail
Condition
Key Mechanisms
Chronic inflammation disrupts bone metabolism through immune dysregulation, pro-inflammatory cytokine release, and oxidative stress, enhancing bone resorption and suppressing formation.
Target Population
Care Setting
Key Highlights
Asthma affects bone health through systemic inflammation and glucocorticoid therapy.
Chronic inflammation and corticosteroid use create a dual risk for bone density loss.
Vitamin D deficiency and physical inactivity further impair bone health in asthma patients.
Management strategies include optimizing inhaled therapies and limiting glucocorticoid exposure.
Routine bone health monitoring is recommended for high-risk populations.
Guideline-Based Recommendations
Diagnosis
Assess bone health in patients with asthma, especially those on long-term glucocorticoids.
Management
Optimize inhaled corticosteroid therapy and consider natural medicines to reduce glucocorticoid use.
Monitoring & Follow-up
Implement routine monitoring of bone health in high-risk asthma patients.
Risks
Long-term glucocorticoid therapy significantly lowers bone mineral density and increases fracture risk.
Patient & Prescribing Data
Patients with asthma, particularly those requiring long-term corticosteroid therapy.
Focus on minimizing glucocorticoid exposure while maintaining asthma control.
Clinical Best Practices
Encourage physical activity to improve mechanical loading on bones.
Monitor vitamin D levels and address deficiencies in asthma patients.
Collaborate across specialties to balance asthma management with bone health.
A large audit of biomedical publications suggests fabricated references are increasingly appearing in peer-reviewed papers — often in ways that are difficult for reviewers and readers to detect.
